Literature DB >> 26067147

Expanding the Phenotypic Spectrum of Olmsted Syndrome.

Neil J Wilson1, Christian Cole2, Leonard M Milstone3, Ana E Kiszewski4, C David Hansen5, Edel A O'Toole6, Mary E Schwartz7, W H Irwin McLean1, Frances J D Smith8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26067147      PMCID: PMC4652067          DOI: 10.1038/jid.2015.217

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
TO THE EDITOR Palmoplantar keratodermas (PPKs) are a group of genetically heterogeneous genodermatoses. Recently mutations in TRPV3 were identified as a cause of the rare form of PPK, Olmsted syndrome (OS; OMIM 614594; Lai-Cheong ; Lin ; Danso-Abeam ; Kariminejad ; Duchatelet ). OS was first reported in 1927 in an Italian American boy with painful palmoplantar keratoderma, deep fissures, pseudoainhum, curved thickened nails, and periorificial hyperkeratosis with fissuring (Olmsted, 1927). About 50 clinical cases of OS have been described, and all generally exhibit the features described by Olmsted as well as some additional features (Mevorah ). In this study, we report the case of six families, referred to the Pachyonychia Congenita Project for the evaluation of painful plantar keratoderma, but lacking pseudoainhum or significant periorificial keratoderma. In each case, after no mutations were identified in the PC-associated keratin genes, KRT6A, KRT6B, KRT6C, KRT16, or KRT17, and in some cases, after other candidate genes including GJB6, DSP, DSG1, KRT5, and KRT14 had been screened, we identified heterozygous missense mutations in TRPV3, thus greatly expanding the phenotypic spectrum of OS. Samples were obtained with written, informed patient consent and ethical approval by a Western Institutional Review Board that complies with principles of the Helsinki Accord. An 18-year-old girl of European ancestry from Family 1 initially noted focal callus formation on the soles at age 4. Severe, painful plantar keratoderma now necessitates periodic use of a wheelchair. She has mild keratoderma on the hands, thin nail plates with koilonychia, and fine slow-growing hair. She has no periorificial keratoderma (Figure 1a, b, c,Supplementary Figure S1 online and Supplementary Table S1 online). A likely diagnosis was PC, but no causative mutations were identified in the PC-related keratin genes nor in other candidate genes. Therefore, a whole-exome sequencing approach was performed (Supplementary Methods online), and data were analyzed for sequence variants in known keratoderma genes. A heterozygous missense mutation, p.Gly573Cys; c,1717G>T, was identified in TRPV3 and confirmed by Sanger sequencing (Supplementary Methods online) but was not present in her unaffected parents or brother. This mutation has been reported in a sporadic case of Olmsted syndrome (Lin ).
Figure 1

Clinical features. Proband of Family 1: (a) severe calluses on the weight-bearing areas of the soles (at age 9), (b) thin nail plates with koilonychia (age 9), and (c) no perioral keratoderma and fine hair, age 12. Proband of Family 2: (d) calluses on the soles of the feet, (e) blisters and peeling of skin on the fingertips, and (f) lack of perioral hyperkeratosis. Proband of Family 3: (g) calluses on the soles, (h) koilonychia of nails, and (i) no perioral lesions. Proband of Family 5: (j) hyperkeratosis on the soles, (k) no palmar hyperkeratosis, and (l) sparse fragile hair, mild lateral perioral fissuring, and no oral leukokeratosis. Images are published with patients' consent.

TRPV3 was considered a candidate gene for five additional families in which no mutations were identified in the PC-associated keratin genes or in other candidate genes. Exons and intron/exon boundaries of TRPV3 were amplified by PCR for Sanger sequencing (Supplementary Methods online). A 7-year-old Brazilian girl in Family 2 presented with easily peeling hyperkeratosis on her toes and feet at about 18 months of age, and these have evolved into painful, focal hyperkeratosis. She has erythema and hyperkeratosis of the distal fingers and subungual hyperkeratosis. She has had transient periorificial hyperkeratosis and her nail plates are normal (Figure 1d, e, f,Table 1, Supplementary Figure S1 online). A previously unreported heterozygous missense mutation, p.Gly568Val; c.1703G>T, was identified (Supplementary Figure S2 online); this mutation was not detected in either of her unaffected parents. Amino acid, p.Gly568 is highly conserved across several species. This mutation is not in the dbSNP database or the NHLBI Exome Variant Server (http://evs.gs.washington.edu/EVS/).
Table 1

Clinical findings in patients with mutations in TRPV3

ReportInheritanceTRPV3 mutationPlantar keratodermaPalmar keratodermaPseudoainhumPeriorificial keratodermaHair
Olmsted's patient  Diffuse-SDiffuse-SPresentPresentDry
Lin et al., 2012ADp.Gly573Ser (4)1M(1)2; Mod(1); S(2)M(1)2; Mod(1); S(2)PresentM(1)2; Mod(1); S(2)Alopecia - M(1); Mod (1); S (2)
Lin et al., 2012ADp.Gly573Cys (1)MMAbsentMAlopecia - M
Lin et al., 2012ADp.Trp692Gly (1)ModModPresentModAlopecia - M
Lai-Cheong et al., 2012ADp.Gly573Ser (1)Diffuse-SDiffuse-SPresentMFine-dry
Danso-Abeam et al., 2013ADp.Gly573Ala (1)Diffuse-SDiffuse-SAbsentSAlopecia-S
Duchatelet et al., 2014bADp.Leu673Phe (1)Diffuse-SDiffuse-SAbsentAbsentFine, dry
Duchatelet et al., 2014aARp.Gly568Cys; p.Gln216_Gly262del (1)Diffuse-S (1); Focal-Mod(1)NRAbsentAbsentFine-dry
Eytan et al., 2014ARp.Trp521Ser (1)Diffuse-SDiffuse-SAbsentPresentSparse
Kariminejad et al., 2014ADp.Trp692Cys (1)Diffuse-SDiffuse-SPresentPresent (Mod)Sparse; fragile
He et al., 2015ADp.Gln580Pro (1)2Focal-ModFocal-ModAbsentAbsentNormal
Family 1ADp.Gly573Cys (1)Focal-SFocal-MAbsentAbsentFine
Family 2ADp.Gly568Val (1)Focal-ModFocal-MAbsentMNormal
Family 3ADp.Gly568Asp (2)2Focal-ModMAbsentMFine
Family 4ADp.Gly568Asp (1)Focal-ModFocal-MAbsentNRNormal
Family 5ADp.Gly573Ser (1)Focal-ModM/transientAbsentM/transientFragile, sparse
Family 6ADp.Gly573Ser (1)Focal-ModMAbsentAbsentNormal

Abbreviations: M, mild; Mod, moderate; NR, not reported; S, severe.

Individual families.

Individuals.

The proband from Family 3, a 38-year-old European female, developed calluses on her feet at the age of 8–9 years. She now has severe plantar pain and difficulty in walking (Figure 1g, h, i, Table 1,Supplementary Figure S1 online). She has thin nail plates with koilonychia. Her father, two paternal uncles and grandmother were similarly affected showing autosomal dominant inheritance of the disorder. A previously unreported heterozygous missense mutation, p.Gly568Asp;c.1703G>A (Supplementary Figure S2 online), was identified in the proband and in one affected paternal uncle; it was not present in an unaffected paternal uncle nor in her mother, (her father is deceased). This mutation is not listed in dbSNP or the NHLBI Exome Variant Server. Interestingly, we found the same mutation, p.Gly568Asp, in Family 4 from South America. The first sign of a skin abnormality in the 25-year-old proband was peeling skin on her feet at age 4 years. Painful, focal keratoses formed on her feet and to a lesser extent on her hands. She has mild periungual hyperkeratosis on her fingers and toes, onychoschizia and longitudinal overcurvature of several toenails. She has no periorificial hyperkeratosis, and her hair is normal (Table 1). No clinical information or DNA samples were available from her parents or from other family members. A 55-year-old man of European ancestry from Family 5 presented with painful calluses on the soles of his feet. Focal hyperkeratoses with thin surrounding rim of erythema started on his heels as a child when he started to walk and spread to the soles of his feet. He has thin nail plates with koilonychia and sparse, fragile hair. He develops severe hyperhidrosis accompanied by burning pain in the feet and bright erythema on the dorsal hands and feet in response to extremes of temperature. He has no palmar hyperkeratosis, but has had transient perioral and periauricular hyperkeratosis (Figure 1j, k, l, Table 1,Supplementary Figure S1 online). He believes that etretinate and acitretin have significantly improved his quality of life. His father was also affected. A heterozygous missense mutation, p.Gly573Ser; c.1717G>A, the most commonly reported mutation to date in TRPV3, was identified in this individual. Mutation p.Gly573Ser, was also found in a 7-year-old girl of European ancestry (Family 6), who developed thickening of the skin on her heels at about 4 years of age (Table 1). She has severe plantar pain and now uses crutches to aid her mobility. Her parents are unaffected. The genetic basis of autosomal dominant OS was recently elucidated (Lin ) when heterozygous missense mutation, p.Gly573Ser, was identified in TRPV3 in a Chinese family. Mutations in TRPV3 were subsequently identified in five additional Chinese families. All developed symptoms before 1 year of age, had varying severity of palmoplantar hyperkeratosis, periorificial hyperkeratosis, alopecia, and severe lesional pain and itch. All but one had constricting digital bands. Several heterozygous mutations have been reported at codons 573; p.Gly573Ser (Lai-Cheong ), p.Gly573Ala (Danso-Abeam ), and p.Gly573Cys (Lin ) and two mutations at codons 692; p.Trp692Gly (Lin ) and p.Trp692Cys (Kariminejad ). The heterozygous missense mutation p.Leu673Phe was found in a patient with OS and erythromelalgia (Duchatelet ). Homozygous missense and compound heterozygous mutations in TRPV3 have been shown to result in recessive OS with (Duchatelet ) or without erythromelalgia (Eytan ). Recently, the heterozygous missense mutation p.Gln580Pro was identified in a family with focal palmoplantar keratoderma (He ), more reminiscent of the cases described here. TRPV3 belongs to the family of transient receptor potential (TRP) cation channels and is widely expressed in keratinocytes and hair follicles (Peier Nilius ) as well as in other tissues including the brain, spinal cord, sensory neurons, and the cornea. Mutations in TRPV3 causing autosomal dominant OS were shown to be gain-of-function mutations resulting in increased TRPV3 activity (Lin ). In this study, two, to our knowledge previously unreported, mutations were identified at codon 568. Interestingly another amino acid substitution at this position, p.Gly568Cys, was recently reported in combination with a splice site mutation, exhibiting autosomal recessive inheritance in this case (Duchatelet ). TRPV3 forms a tetrameric complex, each subunit consists of six transmembrane domains (S1–S6) and a cytoplasmic amino and carboxy termini (Supplementary Figure S2 online). p.Gly568 is within the linker region between S4 and S5, near the boundary of S4. It is predicted that substitution of this glycine is less damaging than substitutions further within the S4–S5 linker such as p.Gly573 (Duchatelet ). In silico prediction tools (PolyPhen and Mutation Taster) predict all three variants at codon 568, p.Gly568Asp, p.Gly568Val (this study), and p.Gly568Cys (Duchatelet ) to be damaging. In our families, no other mutations were identified in TRPV3, and in Family 2, the parents were wild-type for p.Gly568 indicating a de novo mutation, p.Gly568Val, in the proband. Mutation p.Gly568Asp was shown to be dominantly inherited in Family 3; the mutation was identified in the proband and an affected paternal uncle (affected father is deceased). However, in the family reported with p.Gly568Cys in combination with a splice site mutation (Duchatelet ) the unaffected father was heterozygous for p.Gly568Cys and the clinical phenotype of the two affected brothers was significantly different. Overall, these findings suggest that environmental factors/modifier genes may also be involved in determining the phenotypic variability. TRPV3 is involved in many cellular and physiological processes. Recently, Cheng ) demonstrated the important role of TRPV3 in regulating EGFR signaling in hair and skin barrier function using a TRPV3 knockout mouse model that developed a wavy hair coat and curly whiskers in addition to a red, dry scaly skin at birth, reminiscent of mice with a defective skin barrier. Although reported as a thermosensitive cation channel, activated at 30–33 °C, this thermosensory role is unclear (Nilius and Biro, 2013). Interestingly, coexistence of erythromelalgia with OS has been reported (Duchatelet , b), and one of our patients has findings compatible with erythromelalgia. Many OS patients report hyperhidrosis (including four of ours). In this study, heterozygous missense mutations were identified in TRPV3 in six families, (two previously unreported and two recurrent mutations) with painful, palmoplantar keratoderma. Clinically, none were as severe as typical OS (Table 1). The cases we have described expand the phenotypic spectrum of Olmsted syndrome caused by mutations in TRPV3. Mutations in TRPV3 should be considered as a cause of painful PPK even in the absence of periorificial hyperkeratosis and pseudoainhum as described by Olmsted. In contrast and to avoid confusion, painful PPKs caused by mutations in genes other than TRPV3 probably should not be referred to as Olmsted syndrome.
  13 in total

1.  Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.

Authors:  Zhimiao Lin; Quan Chen; Mingyang Lee; Xu Cao; Jie Zhang; Donglai Ma; Long Chen; Xiaoping Hu; Huijun Wang; Xiaowen Wang; Peng Zhang; Xuanzhu Liu; Liping Guan; Yiquan Tang; Haizhen Yang; Ping Tu; Dingfang Bu; Xuejun Zhu; KeWei Wang; Ruoyu Li; Yong Yang
Journal:  Am J Hum Genet       Date:  2012-03-09       Impact factor: 11.025

Review 2.  TRPV3: a 'more than skinny' channel.

Authors:  Bernd Nilius; Tamás Bíró
Journal:  Exp Dermatol       Date:  2013-07       Impact factor: 3.960

Review 3.  TRPV3: time to decipher a poorly understood family member!

Authors:  Bernd Nilius; Tamás Bíró; Grzegorz Owsianik
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

Review 4.  A new TRPV3 missense mutation in a patient with Olmsted syndrome and erythromelalgia.

Authors:  Sabine Duchatelet; Solenn Pruvost; Simon de Veer; Sylvie Fraitag; Patrick Nitschké; Christine Bole-Feysot; Christine Bodemer; Alain Hovnanian
Journal:  JAMA Dermatol       Date:  2014-03       Impact factor: 10.282

5.  Olmsted syndrome in an Iranian boy with a new de novo mutation in TRPV3.

Authors:  A Kariminejad; M Barzegar; F Abdollahimajd; R Pramanik; J A McGrath
Journal:  Clin Exp Dermatol       Date:  2014-04-23       Impact factor: 3.470

6.  Olmsted syndrome caused by a homozygous recessive mutation in TRPV3.

Authors:  Ori Eytan; Dana Fuchs-Telem; Baruch Mevorach; Margarita Indelman; Reuven Bergman; Ofer Sarig; Ilan Goldberg; Noam Adir; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2014-01-24       Impact factor: 8.551

7.  Olmsted syndrome with erythromelalgia caused by recessive transient receptor potential vanilloid 3 mutations.

Authors:  S Duchatelet; L Guibbal; S de Veer; S Fraitag; P Nitschké; M Zarhrate; C Bodemer; A Hovnanian
Journal:  Br J Dermatol       Date:  2014-08-04       Impact factor: 9.302

8.  TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation.

Authors:  Xiping Cheng; Jie Jin; Lily Hu; Dongbiao Shen; Xian-Ping Dong; Mohammad A Samie; Jayne Knoff; Brian Eisinger; Mei-Ling Liu; Susan M Huang; Michael J Caterina; Peter Dempsey; Lowell Evan Michael; Andrzej A Dlugosz; Nancy C Andrews; David E Clapham; Haoxing Xu
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

9.  Recurrent heterozygous missense mutation, p.Gly573Ser, in the TRPV3 gene in an Indian boy with sporadic Olmsted syndrome.

Authors:  J E Lai-Cheong; G Sethuraman; M Ramam; K Stone; M A Simpson; J A McGrath
Journal:  Br J Dermatol       Date:  2012-08       Impact factor: 9.302

10.  Olmsted syndrome: exploration of the immunological phenotype.

Authors:  Dina Danso-Abeam; Jianguo Zhang; James Dooley; Kim A Staats; Lien Van Eyck; Thomas Van Brussel; Shari Zaman; Esther Hauben; Marc Van de Velde; Marie-Anne Morren; Marleen Renard; Christel Van Geet; Heidi Schaballie; Diether Lambrechts; Jinsheng Tao; Dean Franckaert; Stephanie Humblet-Baron; Isabelle Meyts; Adrian Liston
Journal:  Orphanet J Rare Dis       Date:  2013-05-21       Impact factor: 4.123

View more
  7 in total

Review 1.  TRP Channels in Skin Biology and Pathophysiology.

Authors:  Michael J Caterina; Zixuan Pang
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-14

2.  Mutilating Keratoderma with Concomitant Alopecia and Keratoses Follicularis Spinulosa Decalvans: X-Linked Olmsted Syndrome and its Response to Isotretinoin.

Authors:  Gunjan Verma; Kabir Sardana; R K Gautam
Journal:  Indian Dermatol Online J       Date:  2017 Nov-Dec

3.  Olmsted Syndrome Caused by a Heterozygous p.Gly568Val Missense Mutation in TRPV3 Gene.

Authors:  Ji Young Choi; Song Ee Kim; Sang Eun Lee; Soo Chan Kim
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

4.  Mechanisms of proton inhibition and sensitization of the cation channel TRPV3.

Authors:  Haiyuan Wang; Pu Yang; Yungang Lu; Jin Wang; Jaepyo Jeon; Qiaochu Wang; Jin-Bin Tian; Bin Zang; Ye Yu; Michael X Zhu
Journal:  J Gen Physiol       Date:  2021-02-01       Impact factor: 4.086

5.  Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus.

Authors:  Hang Qi; Yuntao Shi; Han Wu; Canyang Niu; Xiaoying Sun; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-05       Impact factor: 11.413

Review 6.  Diagnosis and Management of Inherited Palmoplantar Keratodermas.

Authors:  Bjorn R Thomas; Edel A O'Toole
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875

7.  Abnormal Somatosensory Behaviors Associated With a Gain-of-Function Mutation in TRPV3 Channels.

Authors:  Mahar Fatima; Hannah Slade; Lorraine Horwitz; Angela Shi; Jingyi Liu; Delaney McKinstry; Troy Villani; Haoxing Xu; Bo Duan
Journal:  Front Mol Neurosci       Date:  2022-01-04       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.